Wizzard Software Announces Plans to Acquire MedivoxRx Technologies

PITTSBURGH--(BUSINESS WIRE)-February 6, 2004--Wizzard Software (OTCBB: WIZD)
announced today that it has signed a Letter Of Intent to acquire MedivoxRx
Technologies and their Talking Bottle product line.  The patent pending,
disposable, prescription bottle assists medical patients with verbal
instructions on the correct method of taking prescription medication,
assisting patients in complying with their physician's instructions.

There are approximately 3.2 Billion prescriptions filled each year in the U.S.
and pharmaceutical errors create $45-$80 billion in additional medical
spending with the number one error being identified as labeling problems and
education.  Using unique microprocessor electronics and advanced
text-to-speech technology from Wizzard Software, pharmacists automatically
create a "talking" label while the traditional instruction label is being
printed.  The prescription bottle then talks to the patient when a button is
pressed, describing the name of the medication, the dosage the patient should
consume, the frequency, refill instructions, warnings and other educational
information necessary to educate and help everyone take their prescription
medications properly.

"Usually, Wizzard helps companies add speech to their products and collects
royalties from each unit sold.  Sometimes a company comes to us with a product
idea that management feels has huge potential and we offer to get more
involved with the product, with this project resulting in our acquiring
MedivoxRx", says Chris Spencer, CEO of Wizzard Software.  "Long term, we feel
the potential for this speech based product line is tremendous.  The
acquisition benefits Wizzard's shareholders with a powerful new growth
strategy, and allows Medivox to benefit from becoming part of a publicly
traded entity.  As speech enabled products become part of our daily lives,
Wizzard plans to make acquisitions based on management's ability to identify
customer demand for a specific speech related product or technology."

The problem of non compliance is expected to escalate as the number of elderly
double in the next 25 years.  One out of every four prescriptions written is
for a person over 64.  The elderly are particularly likely to have difficulty
in reading prescription labels in that they tend to have impaired vision and
often cannot distinguish the print and certain colors on prescription labels.
Up to 10% of all hospital admissions are linked to noncompliance, and over 20%
of nursing home admissions are due to noncompliance with medications.
Medication errors and/or adverse drug events kill an estimated 100,000 persons
annually and represent the fourth leading cause of death in the U.S.

According to estimates from investment banking firm Goldman Sachs, the new
Medicare Law could increase spending on prescription drugs by $13 billion, or
9% a year because it will give some seniors new access to coverage and spur
others to seek additional prescriptions.  "We focus our efforts on saving our
commercial and public sector customers money through the effective use of
speech technology solutions," says Gordon Berry, Wizzard's CFO. "If we can
reduce the pharmaceutical industries non compliance liability costs by a
reasonable 1%, and we effectively capture just 10% of these savings as
revenue, this new product line could translate into very substantial annual
revenues for Wizzard."

Wizzard's Board is considering the implementation of a one time, non-cash
paying special dividend based on the structuring of this acquisition to reward
its loyal shareholders.

The closing of the acquisition is subject to usual and customary conditions
for a transaction of this size and type, including satisfactory completion of
due diligence and negotiation and execution of definitive agreements. While
there can be no assurance that Wizzard will be able to complete this
acquisition, Wizzard anticipates that it will close the purchase by February
28, 2004.

About MedivoxRx Technologies

Founded in 2000 by Anthony Mariano, Randy Allnatt, Thomas Mariano and Aimee
Ward, MedivoxRx Technologies is based in Pittsford, NY and offers prescription
medication bottles which "talk" to the patient allowing them to distinguish
what type of medication is in the bottle and information on the dosage and
refill instructions.
Additional information on MedivoxRx Technologies can be found at
www.rxtalks.com .

About Wizzard Software

Founded in 1996, Wizzard Software has become a leader in the speech technology
application development market. Wizzard architects solutions to business
problems using its expertise in consulting, speech development tools and
building speech based applications for the Desktop and Internet. Wizzard has
achieved global recognition because of its expertise with voice communication
whether it is via PC or telephone. Wizzard's successes have lead to expanding
opportunities in both the government and commercial sectors. More information
can be found in Wizzard's Investor's Corner at www.wizzardsoftware.com .

Legal Notice

Legal Notice Regarding Forward-Looking Statements: "Forward-looking
Statements" as defined in the Private Securities litigation Reform Act of 1995
may be included in this news release. These statements relate to future events
or our future financial performance. These statements are only predictions and
may differ materially from actual future results or events. We disclaim any
intention or obligation to revise any forward-looking statements whether as a
result of new information, future developments or otherwise. There are
important risk factors that could cause actual results to differ from those
contained in forward-looking statements, including, but not limited to risks
associated with changes in general economic and business conditions, actions
of our competitors, the extent to which we are able to develop new services
and markets for our services, the time and expense involved in such
development activities, the level of demand and market acceptance of our
services, changes in our business strategies and acts of terror against the
United States.

Contact:
Arthur Douglas and Associates
Art Batson, 407-478-1120 (Investor Relations)


REFERENCES:
(1)  JAMA; 1998; 279, 1200-5. IMO, November 1999
(2)  National Eye Institute
(3)  Center for Health Care Strategies, Inc. and National Academy on an Aging
Society, "Low Health Literacy Increases Expenditures, "U.S. Medicine, May 1999
(4)  National Academy on an Aging Society
(5)  Prevent Blindness America 1994